GlycoMimetics
GLYC
#10327
Rank
C$13.99 M
Marketcap
C$0.22
Share price
-5.42%
Change (1 day)
-46.66%
Change (1 year)

GlycoMimetics (GLYC) - Net assets

Net assets on the balance sheet as of March 2025 : C$4.66 Million

According to GlycoMimetics 's latest financial reports the company has C$4.66 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

GlycoMimetics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$7.62 M-85.03%
2023-12-31$C$50.95 M-12.54%
2022-12-31$C$58.25 M-43.99%
2021-12-31$C$0.10 B-36.39%
2020-12-31$C$0.16 B-18.82%
2019-12-31$C$0.20 B-28.04%
2018-12-31$C$0.27 B85.98%
2017-12-31$C$0.15 B217.24%
2016-12-31$C$47.43 M-15.5%
2015-12-31$C$56.14 M-4.77%
2014-12-31$C$58.95 M1804.92%
2013-12-31$C$3.09 M-75.16%
2012-12-31$C$12.45 M44.82%
2011-12-31$C$8.6 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
bluebird bio
BLUE
-C$79.95 Million-1,814.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$128.61 B 2,758,095.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$119.21 B 2,556,664.68%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
C$109.52 B 2,348,674.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$8.83 Million-289.23%๐Ÿ‡บ๐Ÿ‡ธ USA